Article info

Real-world clinical outcomes following treatment intensification with GLP-1 RA, OADs or insulin in patients with type 2 diabetes on two oral agents (PATHWAY 2-OADs)

Authors

  1. Correspondence to Dr Cyrus Desouza; cdesouza{at}unmc.edu
View Full Text

Citation

Desouza C, Kirk AR, Mangla KK, et al
Real-world clinical outcomes following treatment intensification with GLP-1 RA, OADs or insulin in patients with type 2 diabetes on two oral agents (PATHWAY 2-OADs)

Publication history

  • Received August 17, 2020
  • Revised November 16, 2020
  • Accepted November 17, 2020
  • First published December 29, 2020.
Online issue publication 
December 29, 2020
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.